San
Francisco, Nov 21 According
to a report by Grand View Research, Inc.; the global clinical
microbiology market is anticipated to value USD 16.7 billion by 2025. Growing
demand for diagnosis of infectious diseases using clinical tests is anticipated
to propel market growth over the forecast period (2014 to 2025).
Skilled
and technical workforce and their interpretation of clinical specimen results
is vital in clinical microbiology. Poor turnaround time (TAT) of clinical tests
was one of the major concerns for clinical staff. However, continual technological
advancements are replacing various laboratory instruments with automated
devices to reduce human error and dependency on skilled workforce. This factor
is anticipated to bode well for market growth in near future.
High
prevalence of infectious diseases caused by Zika, Ebola, and other such contagious
pathogens is predicted to fuel adoption of clinical microbiology. Growing cases
of Hospital-Acquired Infections (HAI) is likely to surge demand for
microbiology for diagnosis and monitoring. Continual introduction of automated
systems and innovative designs is expected to further stimulate market growth
during the forecast period.
Browse full research report on Clinical Microbiology Market:
www.grandviewresearch.com/industry-analysis/clinical-microbiology-market
The
worldwide clinical microbiology market can be segregated on the basis of
product type, application, and region. Based on product type, the market can be
categorized into laboratory instruments, microbiology analyzers, and reagents. In
2016, reagents dominated the market and accounted for the largest market share.
The segment includes products such as primers, kits, solutions, and master
mixes that can be used in various diagnostic assays. It is expected to continue
growing at similar pace during the forecast period. Constant repeat purchase
and high cost of specialized kits can drive market growth over next few years.
In addition, rising demand from analytical and therapeutic research projects
can further fuel market growth.
Laboratory
instruments include gram strainers, incubators, bacterial colony counters,
autoclave sterilizers, petri dish filters, and culture systems. Automated
culture systems dominated the global market with 30% share in 2016. Microbiology
analyzers comprise instruments used in mass spectrometry, microscope, and molecular
diagnostics. Microscopes held the largest market share attributed to rising
demand and wider applicability.
Browse more reports of this category
by Grand View Research: www.grandviewresearch.com/industry/medical-devices
Based
on application, the market for clinical microbiology can be classified into
gastrointestinal diseases, respiratory diseases, Sexually Transmitted Diseases
(STDs), Urinary Tract Infections (UTIs), bloodstream infections, periodontal
diseases, and others. In 2016, respiratory diseases dominated the market and held
the largest market share. Growing level of air pollution attributed to rising
industrialization can result in prevalence of respiratory disorders. Such
disorders spread rapidly through easy transfer of contagious pathogens. This,
in turn, can fuel market growth over next few years.
Regional
segmentation includes Europe, North America, Asia Pacific, Latin America, and
Middle East and Africa. In 2016, North America accounted for largest market
share. Highly developed industrial and healthcare sector in U.S. is expected to
surge demand for clinical diagnostic techniques. In addition, tough regulatory
framework and presence of leading market players can further fuel regional market
expansion. Moreover, continuous rise in research on treatment of infectious
diseases and facilitation grants from government healthcare agencies are
expected to contribute to regional growth.
Asia
Pacific is predicted to grow at a rapid pace from 2016 to 2024. Japan is
expected to lead the regional expansion attributed to continual technological
advancements and increasing use of microbial testing in various applications. China
is estimated to witness significant growth during the forecast period. Availability
of advanced manufacturing infrastructure and skilled labor at affordable cost
are likely to result in penetration of major pharmaceutical and medical device
makers in the region. Moreover, booming medical tourism sector can surge demand
for microbial diagnostic and monitoring tests in countries such as Thailand,
India, China, and Malaysia.
Some
of the leading companies operating in the clinical microbiology market are Abbott
Laboratories; Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; Hologic, Inc.;
and Becton, Dickinson and Company. Introduction of automated systems and
innovative designs are likely to intensify competition and change market
dynamics in near future.
Browse press release of this report
by Grand View Research: www.grandviewresearch.com/press-release/global-clinical-microbiology-market
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The company
provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more information:
www.grandviewresearch.com
No comments:
Post a Comment